| ABCM
| adriamycin (doxorubicin), busulphan, cyclophosphamide, melphalan
|
| ACD
| acid citrate dextrose
|
| ACR
| urine albumin/creatinine ratio
|
| aPC
| aberrant plasma cells
|
| ARF
| acute renal failure
|
| ASCT
| autologous stem cell transplant
|
| β2Μ
| β2-microglobulin
|
| B-CLL
| B-cell chronic lymphocytic leukaemia
|
| BJP
| Bence Jones protein
|
| BM
| bone marrow
|
| BMPC
| bone marrow plasma cells
|
| BrdU
| bromodeoxyuridine
|
| CAP
| College of American Pathologists
|
| CCP
| cyclic citrullinated peptides
|
| CKD
| chronic kidney disease
|
| CR
| complete response
|
| CrCl
| creatinine clearance
|
| CRF
| chronic renal failure
|
| CRP
| C-reactive protein
|
| CZE
| capillary zone electrophoresis
|
| CSF
| cerebrospinal fluid
|
| CT
| computerised tomography
|
| CV
| coefficient of variation
|
| C-VAMP
| cyclophosphamide and VAMP
|
| Dex
| dexamethasone
|
| DSS
| disease specific survival
|
| ECLAM
| European Consensus Lupus Activity Measurement
|
| ESR
| erythrocyte sedimentation rate
|
| FcRn
| Brambell Fc receptor
|
| FISH
| fluorescence in situ hybridisation
|
| FITC
| fluorescein isothiocyanate
|
| FLC(s)
| free light chain(s)
|
| GFR
| glomerular filtration rate
|
| GP
| general practitioner
|
| HDM
| high-dose melphalan
|
| HLC
| hevylite
|
| IFE
| immunofixation electrophoresis
|
| iFLC
| involved free light chain
|
| IgG
| immunoglobulin G
|
| Ig(s)
| immunoglobulin(s)
|
| IIMM
| intact immunoglobulin multiple myeloma
|
| κ
| kappa
|
| κ/λ
| kappa/lambda (ratio)
|
| λ
| lambda
|
| LCDD
| light chain deposition disease
|
| LHCDD
| light- and heavy-chain deposition disease
|
| LCMM
| light chain multiple myeloma
|
| LDH
| lactate dehydrogenase
|
| LPL
| lymphoplasmacytic lymphoma
|
| LM
| lymphomatous meningitis
|
| LR
| Likelihood ratio
|
| Mabs
| monoclonal antibodies
|
| MALToma
| mucosa-associated lymphoid tissue lymphoma
|
| MDRD
| modification of diet in renal disease
|
| MGUS
| monoclonal gammopathy of undetermined significance
|
| MIDD
| monoclonal immunoglobulin deposition disease
|
| M-Igs
| monoclonal intact immunoglobulins
|
| MM
| multiple myeloma
|
| M-protein
| monoclonal protein
|
| MRI
| magnetic resonance imaging
|
| MZL
| marginal zone lymphoma
|
| ND
| not determined
|
| NHL
| non-Hodgkin lymphoma
|
| NPV
| negative predictive value
|
| NR
| normal range
|
| NSC
| new scientific company
|
| NSMM
| nonsecretory multiple myeloma
|
| NT-proBNP
| amino-terminal fragment of type B naturetic peptide
|
| PBSCT
| peripheral blood stem cell transplant
|
| PEL
| primary effusion lymphoma
|
| PET
| positron emission tomography
|
| PIgs
| polyclonal immunoglobulins
|
| POEMS
| polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes
|
| PPV
| positive predictive value
|
| PR
| partial response
|
| pSS
| primary Sjögren’s syndrome
|
| QA
| quality assurance
|
| RA
| rheumatoid arthritis
|
| RBCs
| red blood cells
|
| ROC
| receiver operating characteristic
|
| SAP
| serum amyloid P
|
| sCR
| stringent complete response
|
| SD
| stable disease
|
| SDS-AGE
| sodium dodecyl sulfate agarose gel electrophoresis
|
| SDS-PAGE
| sodium dodecyl sulfate polyacrylamide gel electrophoresis
|
| sFLC(s)
| serum free light chain(s)
|
| sIFE
| serum immunofixation electrophoresis
|
| SLE
| systemic lupus erythematosus
|
| SMM
| smouldering (asymptomatic) multiple myeloma
|
| SPE
| serum protein electrophoresis
|
| TRITC
| tetramethylrhodamine isothiocyanate
|
| TSP
| total serum protein (in IFE tests)
|
| TTP
| Time to disease progression
|
| uFLC(s)
| urine free light chain(s)
|
| uIFE
| urine immunofixation electrophoresis
|
| UPE
| urine protein electrophoresis
|
| VAD
| vincristine, adriamycin (doxorubicin), dexamethasone
|
| VAMP
| vincristine, adriamycin (doxorubicin), melphalan, methylprednisolone
|
| VED
| vincristine, epirubicin, dexamethasone
|
| WM
| Waldenström’s macroglobulinaemia
|
